<VariationArchive VariationID="4019" VariationName="NM_206965.2(FTCD):c.990dup (p.Pro331fs)" VariationType="Duplication" Accession="VCV000004019" Version="40" RecordType="classified" NumberOfSubmissions="15" NumberOfSubmitters="15" DateLastUpdated="2024-07-15" DateCreated="2015-03-24" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19058" VariationID="4019">
      <GeneList>
        <Gene Symbol="FTCD" FullName="formimidoyltransferase cyclodeaminase" GeneID="10841" HGNC_ID="HGNC:3974" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46136262" stop="46155579" display_start="46136262" display_stop="46155579" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NT_187626.1" start="4876" stop="14638" display_start="4876" display_stop="14638" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47556175" stop="47575480" display_start="47556175" display_stop="47575480" Strand="-" />
          </Location>
          <OMIM>606806</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206965.2(FTCD):c.990dup (p.Pro331fs)</Name>
      <CanonicalSPDI>NC_000021.9:46145925:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46145925" stop="46145926" display_start="46145925" display_stop="46145926" variantLength="1" positionVCF="46145925" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47565839" stop="47565840" display_start="47565839" display_stop="47565840" variantLength="1" positionVCF="47565839" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>P331fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47565842dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47565842dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46145928dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46145928dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016191.1" sequenceAccession="NG_016191" sequenceVersion="1" change="g.14642dup">
            <Expression>NG_016191.1:g.14642dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320412.2" sequenceAccession="NM_001320412" sequenceVersion="2" change="c.990dup">
            <Expression>NM_001320412.2:c.990dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307341.1" sequenceAccession="NP_001307341" sequenceVersion="1" change="p.Pro331fs">
            <Expression>NP_001307341.1:p.Pro331fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.3" sequenceAccession="NM_006657" sequenceVersion="3" change="c.990dup">
            <Expression>NM_006657.3:c.990dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006648.1" sequenceAccession="NP_006648" sequenceVersion="1" change="p.Pro331fs">
            <Expression>NP_006648.1:p.Pro331fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206965.2" sequenceAccession="NM_206965" sequenceVersion="2" change="c.990dup" MANESelect="true">
            <Expression>NM_206965.2:c.990dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996848.1" sequenceAccession="NP_996848" sequenceVersion="1" change="p.Pro331fs">
            <Expression>NP_996848.1:p.Pro331fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.2" sequenceAccession="NM_006657" sequenceVersion="2" change="c.990dup">
            <Expression>NM_006657.2:c.990dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206965.2" sequenceAccession="NM_206965" sequenceVersion="2" change="c.990dupG" MANESelect="true">
            <Expression>NM_206965.2:c.990dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320412.1" sequenceAccession="NM_001320412" sequenceVersion="1" change="c.990dupG">
            <Expression>NM_001320412.1:c.990dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.3" sequenceAccession="NM_006657" sequenceVersion="3" change="c.990dupG">
            <Expression>NM_006657.3:c.990dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606806.0003" DB="OMIM" />
        <XRef Type="rs" ID="398124234" DB="dbSNP" />
        <XRef ID="CA222968" DB="ClinGen" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 12815595 Fig. 2C to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206965.2(FTCD):c.990dup (p.Pro331fs) AND Glutamate formiminotransferase deficiency" Accession="RCV000004234" Version="30">
        <ClassifiedConditionList TraitSetID="1099">
          <ClassifiedCondition DB="MedGen" ID="C0268609">Glutamate formiminotransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-12" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206965.2(FTCD):c.990dup (p.Pro331fs) AND not provided" Accession="RCV000081452" Version="26">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-10-01" SubmissionCount="5">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206965.2(FTCD):c.990dup (p.Pro331fs) AND Inborn genetic diseases" Accession="RCV002512745" Version="4">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206965.2(FTCD):c.990dup (p.Pro331fs) AND FTCD-related disorder" Accession="RCV003390640" Version="4">
        <ClassifiedConditionList TraitSetID="90961">
          <ClassifiedCondition>FTCD-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-12" NumberOfSubmissions="15" NumberOfSubmitters="15" DateCreated="2015-03-24" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(10); Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">12815595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26633545</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29178637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30740726</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(10); Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2017-11-05">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-11-05">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-12-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70001" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FTCD-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">FTCD-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1099" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1296" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glutamate formiminotransferase deficiency</ElementValue>
                <XRef ID="59761008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminotransferase deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamicaciduria (FIGLU-uria)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arakawa syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic aciduria</ElementValue>
                <XRef ID="MONDO:0009240" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9279" />
                <XRef ID="9279" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glutamate formiminotransferase deficiency is an autosomal recessive disorder and the second most common inborn error of folate metabolism. Features of a severe phenotype include elevated levels of formiminoglutamate (FIGLU) in the urine in response to histidine administration, megaloblastic anemia, and mental retardation. Features of a mild phenotype include high urinary excretion of FIGLU in the absence of histidine administration, mild developmental delay, and no hematologic abnormalities (summary by Hilton et al., 2003).</Attribute>
                <XRef Type="MIM" ID="229100" DB="OMIM" />
              </AttributeSet>
              <XRef ID="51208" DB="Orphanet" />
              <XRef ID="C0268609" DB="MedGen" />
              <XRef ID="MONDO:0009240" DB="MONDO" />
              <XRef Type="MIM" ID="229100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24400" SubmissionDate="2020-07-04" DateLastUpdated="2020-07-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606806.0003_GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" title="FTCD, 1-BP DUP, 990G_GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000024400" DateUpdated="2020-07-11" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with glutamate formiminotransferase deficiency (229100), Hilton et al. (2003) found a c.990dupG mutation in hemizygous state in the FTCD gene, with quantitative PCR indicating that the other allele contained a deletion. This mutation was originally reported as 1033insG but was corrected in an erratum.</Attribute>
              <Citation>
                <ID Source="PubMed">12815595</ID>
              </Citation>
              <XRef DB="OMIM" ID="229100" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 18 of 20 patients with glutamate formiminotransferase deficiency, Majumdar et al. (2017) identified the c.990dupG mutation in homozygous state in 4 patients and in compound heterozygous state in 14 patients (see, e.g., 606806.0004-606806.0006). The recurrent c.990dupC variant had a frequency of 0.002 in the ExAC database.</Attribute>
              <Citation>
                <ID Source="PubMed">29178637</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <Name>FTCD, 1-BP DUP, 990G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 990G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606806.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="455708" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2015-09-29">
        <ClinVarSubmissionID localKey="20182|OMIM:229100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000245484" DateUpdated="2023-03-11" DateCreated="2015-09-29" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.3:c.990dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="229100" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">26633545</ID>
        </Citation>
        <StudyName>Adult_WES</StudyName>
        <StudyDescription>Variants from cases considered to be molecularly diagnosed in paper reporting WES in adults.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>GIM_Adult_WES</SubmissionName>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7533464" SubmissionDate="2023-08-18" DateLastUpdated="2023-08-19" DateCreated="2023-08-19">
        <ClinVarSubmissionID localKey="Chr.21_47565839_47565839_G_GC|not provided" />
        <ClinVarAccession Accession="SCV004026481" DateUpdated="2023-08-19" DateCreated="2023-08-19" Type="SCV" Version="1" SubmitterName="Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden" OrgID="505632" OrganizationCategory="clinic" OrgAbbreviation="KGE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS3, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="GC" referenceAllele="G" start="47565839" stop="47565839" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13773719</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7684957" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="1464932|FTCD-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004112641" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The FTCD c.990dupG variant is predicted to result in a frameshift and premature protein termination (p.Pro331Alafs*2). This variant has been reported in the homozygous state or in the heterozygous state with a second pathogenic variant in patients with autosomal recessive glutamate formiminotransferase deficiency. The reported FTCD variants were confirmed to be compound heterozygous in at least one reported family (e.g., Majumdar et al. 2017. PubMed ID: 29178637). The c.990dup variant introduces a premature stop codon between the enzyme formiminotransferase and cyclodeaminase domains. This variant has been reported to lead to a truncated FTCD enzyme missing the cyclodeaminase domain (Hilton et al. 2003. PubMed ID: 12815595, reported as c.1033insG). Additional predicted FTCD loss-of-function variants have been reported in association with formiminoglutamic aciduria (Human Gene Mutation Database; https://www.hgmd.cf.ac.uk/). Several outside laboratories have classified this variant as pathogenic or likely pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/4019/). Taken together, we classify this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001320412.1:c.990dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FTCD-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7702552" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="NM_006657.3:c.990dupG|MedGen:C0268609" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004122875" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815595</ID>
          </Citation>
          <Comment>Variant summary: FTCD c.990dupG (p.Pro331AlafsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.0029 in 112050 control chromosomes in the gnomAD database, including 2 homozygotes. c.990dupG (also known as c.1033insG) has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Glutamate Formiminotransferase Deficiency (example: Hilton_2003, Ahrens-Nicklas_2019). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence that the variant results in a truncated protein and loss of the cyclodeaminase domain (Hilton_2003). Eleven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classfied the variant as pathogenic/likely pathogenic (n=10) or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.3:c.990dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268609" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963927" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="6fb2911dc88df45abaadfe1703c64206c6faeaaec7b050f504769eb5a3ce4ae5|OMIM:229100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002023766" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.3:c.990dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="229100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1598240" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="745785|MedGen:C0268609" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000826419" DateUpdated="2024-02-20" DateCreated="2018-10-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro331Alafs*2) in the FTCD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FTCD are known to be pathogenic (PMID: 29178637, 30740726). This variant is present in population databases (rs398124234, gnomAD 1.0%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individuals with glutamate formiminotransferase deficiency (PMID: 12815595, 29178637, 30740726). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4019). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.47565839_47565840insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268609" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8977934" SubmissionDate="2024-03-14" DateLastUpdated="2024-03-23" DateCreated="2024-03-23">
        <ClinVarSubmissionID localKey="genomeconnect_31626_1" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV004801641" DateUpdated="2024-03-23" DateCreated="2024-03-23" Type="SCV" Version="1" SubmitterName="GenomeConnect - Brain Gene Registry" OrgID="508359" OrganizationCategory="patient registry" OrgAbbreviation="GenomeConnect - BGR" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant classified as Pathogenic and reported on 09-23-2014 by Fulgent Diagnostics . Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2014-09-23" integerValue="500105">Fulgent Genetics, Fulgent Genetics</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">genomeconnect_31626_1</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2014-08-28" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000118" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.2:c.990dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="229100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BGR 3.2024 NA</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4897247" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2022-04-28">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_206965_2_FTCD_c_990dupG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002503860" DateUpdated="2024-04-15" DateCreated="2022-04-28" Type="SCV" Version="2" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12815595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26633545</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Comment>This sequence change is a duplication of 1 bp in exon 9 (of 14) of FTCD that is predicted to create a premature termination codon at position 332 (p.(Pro331Alafs*2)). It is expected to result in nonsense mediated decay, in a gene where loss of function is an established mechanism of disease (ClinGen). The variant is present in a large population cohort at a frequency of 0.3% (rs398124234, 465/141,806 alleles, 3 homozygotes in gnomAD v2.1). It has been identified in the homozygous and the compound heterozygous state in multiple individuals with formimidoyltransferase cyclodeaminase deficiency with elevated levels of formiminoglutamate (FIGLU) in the urine or blood (PMID: 12815595, 26633545, 29178637, 30740726). Based on the classification scheme RMH Modified ACMG Guidelines v1.3.2, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PM3_VeryStrong, PP4, BS1.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6010</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206965.2:c.990dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009240" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_12</SubmissionName>
          <SubmissionName>submission_41</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6440897" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a815954|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003749669" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12815595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Comment>The c.990dupG (p.P331Afs*2) alteration, located in exon 9 (coding exon 9) of the FTCD gene, consists of a duplication of G at position 990, causing a translational frameshift with a predicted alternate stop codon after 2 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been reported in the homozygous and compound heterozygous state with a second FTCD alteration in patients with glutamate formiminotransferase deficiency (Ahrens-Nicklas, 2019; Hilton, 2003; Majumdar, 2017). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.2:c.990dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5052612" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="119309|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002585909" DateUpdated="2024-07-15" DateCreated="2022-10-22" Type="SCV" Version="12" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>FTCD: PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="GC" referenceAllele="G" start="47565839" stop="47565839" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1191014" SubmissionDate="2017-10-05" DateLastUpdated="2015-03-24" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="37734748" />
        <ClinVarAccession Accession="SCV000610959" DateUpdated="2015-03-24" DateCreated="2015-03-24" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.003603</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" Strand="+" alternateAllele="C" referenceAllele="-" start="47565839" stop="47565840" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="421437" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-31" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="3044_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000233112" DateUpdated="2019-07-31" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000113383" DateChanged="2018-02-14" Version="3" />
        </ReplacedList>
        <Classification DateLastEvaluated="2016-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="23" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="11" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="11" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="C" referenceAllele="-" start="47565839" stop="47565840" variantLength="2" />
            <GeneLocation>NM_006657.2:Ex9</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI031903" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">23757202</ID>
        </Citation>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=FTCD</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL001</SubmissionName>
          <SubmissionName>EGL002</SubmissionName>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933094" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000021.9:g.46145925_46145926insC|OMIM:229100" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002516406" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.46145925_46145926insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="229100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1103940" SubmissionDate="2022-03-02" DateLastUpdated="2023-03-04" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="GDXSV:221988" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000568833" DateUpdated="2023-03-04" DateCreated="2015-03-24" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Functional studies show a truncated protein, loss of the cyclodeaminase domain, but normal formiminotransferase activity; study authors suggest second step in reaction is hindered despite intact formiminotransferase activity (Hilton et al., 2003); This variant is associated with the following publications: (PMID: 12815595, 25689098, 29178637, 31980526, 34426522)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:757271</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.2:c.990dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_92_20220302054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4933094" TraitType="Disease" MappingType="XRef" MappingValue="229100" MappingRef="OMIM">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5052612" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8977934" TraitType="Disease" MappingType="XRef" MappingValue="229100" MappingRef="OMIM">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7702552" TraitType="Disease" MappingType="XRef" MappingValue="C0268609" MappingRef="MedGen">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24400" TraitType="Disease" MappingType="Name" MappingValue="GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7684957" TraitType="Disease" MappingType="Name" MappingValue="FTCD-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="FTCD-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4897247" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009240" MappingRef="MONDO">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1191014" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963927" TraitType="Disease" MappingType="XRef" MappingValue="229100" MappingRef="OMIM">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8977934" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000118" MappingRef="HP">
        <MedGen CUI="C4021819" Name="Phenotypic abnormality" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="455708" TraitType="Disease" MappingType="XRef" MappingValue="229100" MappingRef="OMIM">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1598240" TraitType="Disease" MappingType="XRef" MappingValue="C0268609" MappingRef="MedGen">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7533464" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1103940" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="421437" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6440897" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="3" DateDeleted="2020-07-19">SCV000436896</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

